Why Is the Flu Hitting So Hard This Year?
If it feels like everyone around you is coughing and sneezing, you’re not imagining it. The U.S. is grappling with its worst flu season in a quarter-century, according to the Centers for Disease Control and Prevention (CDC). As of January 3, the CDC estimates a staggering 15 million illnesses, 180,000 hospitalizations, and 7,400 deaths. But here's where it gets controversial: could a new virus strain be outsmarting our vaccines? And this is the part most people miss—our behavior might be playing a bigger role than we think.
A New Strain on the Scene
Part of the blame falls on a newcomer called subclade K, a flu strain with unique ‘antigenic differences’ from the ones included in this year’s vaccine. Yonatan Grad, a professor of immunology and infectious diseases at Harvard T.H. Chan School of Public Health, explains that these differences could reduce the vaccine’s effectiveness. In an interview edited for clarity, Grad dives into why some flu seasons are worse than others and what we can do to protect ourselves.
Why Do Some Flu Seasons Pack a Bigger Punch?
The severity of a flu season boils down to two key factors. First, how many people are susceptible to the circulating strain? Immunity from past infections or vaccinations can fade over time, especially as the virus evolves. Second, human behavior plays a huge role. Remember the COVID-19 lockdowns? With minimal interaction, flu cases plummeted. But now, with life back in full swing, the flu is spreading like wildfire.
This Year’s Strain: A Blast from the Past?
Flu viruses come in two main types: A and B. Historically, two strains of flu B circulated annually—Victoria and Yamagata. But Yamagata seems to have vanished during the pandemic. This year, the H3N2 subtype of flu A is dominating. While flu B is generally milder, H3N2 is known to be more severe, though scientists aren’t entirely sure why.
Here’s where it gets fascinating: the first flu strain you encounter in life might shape your immune response forever. People born before 1968, when H3N2 emerged, may have weaker immunity to it, which could explain its severity. But is this theory the whole story? It’s a question worth debating.
Vaccine Mismatch: Fact or Fiction?
You’ve probably heard that this year’s flu vaccine isn’t a perfect match for the circulating strain. The vaccine contains a subclade J.2 virus, which is antigenically different from the dominant subclade K. This raises concerns about its effectiveness. However, a recent study suggests the vaccine isn’t as off the mark as initially thought. People are still developing some immunity to subclade K after vaccination, and early estimates show the vaccine’s effectiveness is on par with previous H3N2 seasons.
The Timing Trap in Vaccine Development
The strains for the flu vaccine are chosen months in advance—usually in February for the Northern Hemisphere. This early decision is necessary because vaccines are primarily grown in chicken eggs, a slow process. Subclade K emerged in spring 2025, long after this year’s vaccine strains were finalized. This begs the question: could faster vaccine technologies, like mRNA, help us stay ahead of the flu? Unfortunately, with federal funding cuts, we might not find out anytime soon.
Is It Too Late to Get Vaccinated?
Absolutely not! With flu season expected to linger for months, it’s still worth getting your shot. It takes about two weeks for immunity to build, and protection lasts four to six months. Ideally, get vaccinated around Halloween for peak protection in mid-winter. And don’t forget the COVID-19 precautions we’ve all grown accustomed to: masking, hand hygiene, and avoiding crowded spaces.
COVID-19: Why Isn’t It Surging This Winter?
While there was a small uptick in COVID cases this fall, it hasn’t exploded like the flu. Grad attributes this to population immunity from past infections and vaccinations. But as immunity wanes and new variants emerge, we could see periodic surges in the future.
Final Thoughts: A Call for Discussion
This flu season has been a stark reminder of the virus’s unpredictability. But is our current approach to vaccine development enough? Should we invest more in faster technologies like mRNA? And how much does our behavior truly impact flu spread? Let’s keep the conversation going—share your thoughts in the comments!
